Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Haematology and Serum Biochemistry Parameters and Variations in the Eurasian Beaver (Castor fiber).

Girling SJ, Campbell-Palmer R, Pizzi R, Fraser MA, Cracknell J, Arnemo J, Rosell F.

PLoS One. 2015 Jun 12;10(6):e0128775. doi: 10.1371/journal.pone.0128775. eCollection 2015.

2.

The frequency, longitudinal course, clinical associations, and causes of emotional distress during primary treatment of cerebral glioma.

Rooney AG, McNamara S, Mackinnon M, Fraser M, Rampling R, Carson A, Grant R.

Neuro Oncol. 2013 May;15(5):635-43. doi: 10.1093/neuonc/not009. Epub 2013 Feb 26.

3.

Screening for major depressive disorder in adults with glioma using the PHQ-9: a comparison of patient versus proxy reports.

Rooney AG, McNamara S, Mackinnon M, Fraser M, Rampling R, Carson A, Grant R.

J Neurooncol. 2013 May;113(1):49-55. doi: 10.1007/s11060-013-1088-4. Epub 2013 Feb 24.

PMID:
23436131
4.

Screening for major depressive disorder in adults with cerebral glioma: an initial validation of 3 self-report instruments.

Rooney AG, McNamara S, Mackinnon M, Fraser M, Rampling R, Carson A, Grant R.

Neuro Oncol. 2013 Jan;15(1):122-9. doi: 10.1093/neuonc/nos282. Epub 2012 Dec 9.

5.

Frequency, clinical associations, and longitudinal course of major depressive disorder in adults with cerebral glioma.

Rooney AG, McNamara S, Mackinnon M, Fraser M, Rampling R, Carson A, Grant R.

J Clin Oncol. 2011 Nov 10;29(32):4307-12. doi: 10.1200/JCO.2011.34.8466. Epub 2011 Oct 11.

PMID:
21990406
6.

How does a standardized care plan facilitate the practice of pharmaceutical care planning in mental health settings across Scotland?

Fraser M, Fraser K, Davies P, Shaw T, Walker A.

Int J Pharm Pract. 2009 Feb;17(1):47-52.

PMID:
20218029
7.

A model intervention to improve primary health care for adults with developmental disabilities.

Moss K, Fraser M, Pathman D.

Intellect Dev Disabil. 2008 Oct;46(5):390-2. doi: 10.1352/2008.46:390-392. No abstract available.

PMID:
19090641
8.

dna and DNA: linked for life.

Fraser MC.

Dermatol Nurs. 2008 Apr;20(2):102. No abstract available.

PMID:
18549124
9.

Genetic testing for melanoma predisposition: current challenges.

Gerstenblith MR, Goldstein AM, Tucker MA, Fraser MC.

Cancer Nurs. 2007 Nov-Dec;30(6):452-9; quiz 462-3. Review.

PMID:
18025917
10.

Recent tanning bed use: a risk factor for melanoma.

Buckel TB, Goldstein AM, Fraser MC, Rogers B, Tucker MA.

Arch Dermatol. 2006 Apr;142(4):485-8.

PMID:
16618869
11.

Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations.

Goldstein AM, Landi MT, Tsang S, Fraser MC, Munroe DJ, Tucker MA.

Cancer Epidemiol Biomarkers Prev. 2005 Sep;14(9):2208-12.

12.

Genetic testing for inherited predisposition to melanoma: has the time come?

Fraser MC, Goldstein AM, Tucker MA; Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, Maryland, USA..

J Drugs Dermatol. 2004 Jan-Feb;3(1):93-5. No abstract available.

PMID:
14964756
13.

A natural history of melanomas and dysplastic nevi: an atlas of lesions in melanoma-prone families.

Tucker MA, Fraser MC, Goldstein AM, Struewing JP, King MA, Crawford JT, Chiazze EA, Zametkin DP, Fontaine LS, Clark WH Jr.

Cancer. 2002 Jun 15;94(12):3192-209.

14.

Applications of advances in molecular biology and genomics to clinical cancer care.

Loud JT, Peters JA, Fraser M, Jenkins J.

Cancer Nurs. 2002 Apr;25(2):110-22; quiz 123-4. Review.

PMID:
11984099

Supplemental Content

Loading ...
Support Center